Top Markets
Coin of the day
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
Rankning i aktier #34084
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
Aktiekurs
$0.02082992
Senast synkroniserad: 2026-08-14
Marknadsvärde
$6.27M
Förändring (1 dag)
-3.31%
Förändring (1 år)
-51.62%
Land
RU
Handel PJSC Pharmsynthez (LIFE)

Kategori

Aktiekurshistorik för PJSC Pharmsynthez (LIFE)
Högsta slutkurs: $0.02 den 2026-08-01

Lägsta slutkurs: $0.76 den 2010-11-01
Aktiekurshistorik för PJSC Pharmsynthez från 2010 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -9.44%
2025 30.97%
2024 -44.82%
2023 -11.95%
2022 -18.74%
2021 -19.66%
2020 45.23%
2019 -22.41%
2018 -56.43%
2017 -26.82%
2016 72.01%
2015 -33.83%
2014 -51.22%
2013 7.71%
2012 -30.67%
2011 -14.49%
2010 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE